NCT02802579

Brief Summary

Coronary arterial disease is a risk factor for bariatric surgery and might be a predictor for later major adverse coronary events. Diagnosis of coronary arterial disease would thus be desirable for obese patients, however percutaneous angiography is an invasive procedure and associated with a certain morbidity in obese patients. In this study the investigators would like to assess whether dual source CT angiography can be used for diagnosis of coronary arterial disease in severely obese patients and which settings yield the best image quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 14, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 16, 2016

Completed
Last Updated

June 17, 2016

Status Verified

June 1, 2016

Enrollment Period

8 years

First QC Date

June 14, 2016

Last Update Submit

June 16, 2016

Conditions

Keywords

obesitydual source CTcoronary CT angiographyprognosisbariatric surgerygastric bypass surgerycoronary arterial diseasemajor adverse coronary event

Outcome Measures

Primary Outcomes (2)

  • Image quality

    Coronary arteries (with at least 1 mm diameter at their origin) were segmented according to the 15-segment model of the American Heart Association (Austen 1975). Subjective image quality was judged for each coronary artery segment on a 4-point scale (Leschka 2007) : 1. = excellent; 2. = good, minor artifacts; 3. = fair, moderate artifacts but still diagnostic; 4. = non-diagnostic

    7 days

  • coronary artery stenosis

    Significant coronary artery stenosis was defined as more than 50% narrowing of luminal diameter. Stenosis assessment was performed by a radiologist not involved in image quality assessment.

    7 days

Secondary Outcomes (4)

  • Image noise

    7 days

  • Signal-to-noise ratio (SNR)

    7 days

  • contrast-to-noise ratio (CNR)

    7 days

  • Major adverse cardiovascular events (MACE)

    7 years

Study Arms (3)

A: standard protocol

ACTIVE COMPARATOR

Standard dual-source computed tomography coronary angiography protocol

Radiation: standard protocol

B: enhanced protocol

EXPERIMENTAL

enhanced dual-source computed tomography coronary angiography protocol

Radiation: enhanced protocol

C: enhanced obesity protocol

EXPERIMENTAL

enhanced obesity-mode dual-source computed tomography coronary angiography protocol

Radiation: enhanced obesity protocol

Interventions

tube voltage: 120 kV current time product: 350 mAs/rotation rotation: 90° (with two detectors in a 90° angle)

Also known as: dual source computed tomography coronary angiography
A: standard protocol

tube voltage: 140 kV current time product: 350 mAs/rotation rotation: 90° (with two detectors in a 90° angle)

Also known as: dual source computed tomography coronary angiography
B: enhanced protocol

tube voltage: 140 kV current time product: 350 mAs/rotation rotation: 180° (with two detectors in a 90° angle)

Also known as: dual source computed tomography coronary angiography
C: enhanced obesity protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • morbid obesity (BMI \>35 kg/m²)
  • intention to undergo bariatric surgery
  • increased risk for coronary artery disease (based on PROCAM score)

You may not qualify if:

  • kidney insufficiency (serum creatinine \>100 µmol/l, creatinine clearance \<50 ml/min)
  • allergy to iodine containing contrast agents
  • hyperthyroidism
  • metformin medication
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cantonal Hospital St Gallen

Sankt Gallen, 9007, Switzerland

Location

Related Publications (4)

  • Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975 Apr;51(4 Suppl):5-40. doi: 10.1161/01.cir.51.4.5. No abstract available.

    PMID: 1116248BACKGROUND
  • Leschka S, Scheffel H, Desbiolles L, Plass A, Gaemperli O, Valenta I, Husmann L, Flohr TG, Genoni M, Marincek B, Kaufmann PA, Alkadhi H. Image quality and reconstruction intervals of dual-source CT coronary angiography: recommendations for ECG-pulsing windowing. Invest Radiol. 2007 Aug;42(8):543-9. doi: 10.1097/RLI.0b013e31803b93cf.

    PMID: 17620936BACKGROUND
  • Husmann L, Alkadhi H, Boehm T, Leschka S, Schepis T, Koepfli P, Desbiolles L, Marincek B, Kaufmann PA, Wildermuth S. Influence of cardiac hemodynamic parameters on coronary artery opacification with 64-slice computed tomography. Eur Radiol. 2006 May;16(5):1111-6. doi: 10.1007/s00330-005-0110-4. Epub 2006 Jan 28.

    PMID: 16607499BACKGROUND
  • Lembcke A, Wiese TH, Schnorr J, Wagner S, Mews J, Kroencke TJ, Enzweiler CN, Hamm B, Taupitz M. Image quality of noninvasive coronary angiography using multislice spiral computed tomography and electron-beam computed tomography: intraindividual comparison in an animal model. Invest Radiol. 2004 Jun;39(6):357-64. doi: 10.1097/01.rli.0000123316.10765.6c.

    PMID: 15167102BACKGROUND

MeSH Terms

Conditions

Obesity, MorbidObesity

Interventions

AIEOP acute lymphoblastic leukemia protocol

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sebastian Leschka, MD

    Cantonal Hospital of St. Gallen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician

Study Record Dates

First Submitted

June 14, 2016

First Posted

June 16, 2016

Study Start

December 1, 2007

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

June 17, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will not share

Locations